Top neuro stories of February: Marijuana and brain health, hemorrhage detection device

Healio’s most-viewed neurology stories in February highlight evidence of potential dangers of marijuana for brain health, the FDA expanding the indication of a hemorrhage detection device and an NIH grant to a biotech firm.

AHA: Effects of marijuana on brain health, function still unclear

In a new statement, the American Heart Association presented scientific evidence that challenges the belief that marijuana is harmless and highlights uncertainty about the drug’s effect on brain health. Read more.

FDA gives pediatric indication to device that detects traumatic brain hemorrhage

The FDA granted expanded indication to Infrascanner, a handheld device used for detecting traumatic supratentorial hematomas in adults, to now include pediatric patients aged 2 years and older. Read more.

NIH awards $1.8 million to biotech firm for neurodegenerative disease research

The National Institute of General Medical Sciences, a division of the NIH, awarded $1.8 million to Integrated Micro-Chromatography Systems Inc. for phase 2 of its fast track Small Business Innovation Research grant, according to a release. Read more.

Older Americans’ interest in Aduhelm limited despite publicity, FDA approval

Publicity surrounding FDA approval of Aduhelm for Alzheimer’s disease did not contribute to understanding of nor enthusiasm for the drug among middle-aged and older adults, according to survey results published in JAMA Network Open. Read more.

Revised criteria for Creutzfeldt-Jakob disease improve diagnosis

Revisions to diagnostic criteria for sporadic Creutzfeldt-Jakob disease have led to greater accuracy in both clinical care and surveillance, according to a European study published in JAMA Network Open. Read more.